AG 1505
Alternative Names: AG-1505Latest Information Update: 19 Nov 2021
At a glance
- Originator Ahn-Gook Pharmaceutical
- Class Cardiovascular therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cardiovascular disorders
Most Recent Events
- 01 Nov 2021 Early research in Cardiovascular disorders in South Korea (Ahn-Gook Pharmaceutical pipeline, November 2021)